| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.22 | 4e-09 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.2 | 6e-08 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 7e-07 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.25 | 8e-06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |